Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus

被引:8
|
作者
Crisman, Celina M. [1 ]
Patel, Ankur R. [2 ,3 ]
Winston, Graham [4 ]
Brennan, Cameron W. [2 ,3 ]
Tabar, Viviane [2 ,3 ]
Moss, Nelson S. [2 ,3 ]
机构
[1] UMass Mem Med Ctr, Dept Neurosurg, Worcester, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Brain Metastasis Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, New York, NY USA
基金
美国国家卫生研究院;
关键词
Choroid plexus; Intraventricular metastasis; Renal cell carcinoma; Stereotactic body radiotherapy; Stereotactic radiosurgery; BRAIN METASTASES; PROGNOSTIC-FACTORS; SURVIVAL; RADIOSURGERY; THERAPY;
D O I
10.1016/j.wneu.2020.03.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Intraventricular metastatic brain tumors account for a small, but challenging, fraction of metastatic brain tumors (0.9%-4.5%). Metastases from renal cell carcinoma (RCC) account for a large portion of these intraventricular tumors. Although patient outcomes have been assumed to be poor, these have not been reported in a modern series with a multimodality treatment paradigm of radiotherapy (RT), resection, and cerebrospinal fluid (CSF) diversion. We have presented the first case series of patients with intraventricular metastatic tumors from RCC. METHODS: We performed a single-institution retrospective review of patients with intraventricular RCC metastases treated from January 2003 to January 2019. Volumetric analysis was used to delineate the tumor size and the Kaplan-Meier method to evaluate the survival data. RESULTS: A total of 22 intraventricular RCC metastases were identified in 19 patients with 61.3 patient-years of follow-up. The median patient age was 64 years, and the median tumor volume was 2.2 cm(3). Overall, 19 metastases had been treated initially with RT. Of these, 16 had received stereotactic body RT and 3 had received whole brain RT. Three tumors were surgically excised and had received adjuvant stereotactic body RT in the upfront setting. Although 5 patients had presented with obstructive hydrocephalus, none had required CSF diversion. After treatment, 5 metastases had progressed, resulting in 1- and 3-year progression-free survival rates of 81.6% and 68%, respectively. The median overall survival was 2.8 years, with 1- and 5-year overall survival rates of 76.7% and 28.3%, respectively. Leptomeningeal carcinomatosis was not observed. CONCLUSIONS: Despite the relatively limited overall survival for this population with metastatic cancer, comparable to contemporary parenchymal brain metastasis cohorts, reasonable local central nervous system control was achieved in most patients using a paradigm of focal RT and resection, where indicated. Finally, CSF diversion was not required even in patients presenting with hydrocephalus.
引用
收藏
页码:E7 / E13
页数:7
相关论文
共 50 条
  • [1] Long-term management of bilateral metastases of renal cell carcinoma to the choroid plexus
    Hillard, VH
    Musunuru, K
    Hasan, I
    Zia, S
    Hirschfeld, A
    ACTA NEUROCHIRURGICA, 2003, 145 (09) : 793 - 797
  • [2] The ventricular system and choroid plexus as a primary site for renal cell carcinoma metastasis
    Shapira, Yuval
    Hadelsberg, Uri P.
    Kanner, Andrew A.
    Ram, Zvi
    Roth, Jonathan
    ACTA NEUROCHIRURGICA, 2014, 156 (08) : 1469 - 1474
  • [3] The ventricular system and choroid plexus as a primary site for renal cell carcinoma metastasis
    Yuval Shapira
    Uri P. Hadelsberg
    Andrew A. Kanner
    Zvi Ram
    Jonathan Roth
    Acta Neurochirurgica, 2014, 156 : 1469 - 1474
  • [4] The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery
    Cochran, D. Clay
    Chan, Michael D.
    Aklilu, Mebea
    Lovato, James F.
    Alphonse, Natalie K.
    Bourland, J. Daniel
    Urbanic, James J.
    McMullen, Kevin P.
    Shaw, Edward G.
    Tatter, Stephen B.
    Ellis, Thomas L.
    JOURNAL OF NEUROSURGERY, 2012, 116 (05) : 978 - 983
  • [5] Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases
    Uezono, Haruka
    Nam, David
    Kluger, Harriet M.
    Sznol, Mario
    Hurwitz, Michael
    Yu, James B.
    Chiang, Veronica L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (09): : 495 - 501
  • [6] Outcome Predictors of Gamma Knife Radiosurgery for Renal Cell Carcinoma Metastases
    Kano, Hideyuki
    Iyer, Aditya
    Kondziolka, Douglas
    Niranjan, Ajay
    Flickinger, John C.
    Lunsford, L. Dade
    NEUROSURGERY, 2011, 69 (06) : 1232 - 1239
  • [7] Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomes
    Ressler, Hadley W.
    Cramer, Christina K.
    Isom, Scott
    Mccormack, Michael
    Ruiz, Jimmy
    Xing, Fei
    Li, Wencheng
    Whitlow, Christopher T.
    White, Jaclyn J.
    Laxton, Adrian W.
    Tatter, Stephen B.
    Chan, Michael D.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 238
  • [8] CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA
    Hara, Wendy
    Tran, Phuoc
    Li, Gordon
    Su, Zheng
    Puataweepong, Putipun
    Adler, John R., Jr.
    Soltys, Scott G.
    Chang, Steven D.
    Gibbs, Iris C.
    NEUROSURGERY, 2009, 64 (02) : A26 - A32
  • [9] Papillary Renal Cell Carcinoma With Cutaneous Metastases
    Srinivasan, Nandakumar
    Pakala, Aneesh
    Al-Kali, Aref
    Rathi, Shradha
    Ahmad, Waqar
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (05) : 458 - 461
  • [10] Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
    Ma, Jennifer
    del Balzo, Luke
    Walch, Henry
    Khaleel, Sari
    Knezevic, Andrea
    Flynn, Jessica
    Zhang, Zhigang
    Eichholz, Jordan
    Doshi, Sahil D.
    Voss, Martin H.
    Freeman, Benjamin
    Hakimi, A. Ari
    Lee, Chung-Han
    Bale, Tejus A.
    Kelly, Daniel
    Mueller, Boris A.
    Mann, Justin
    Yu, Yao
    Zinovoy, Melissa
    Chen, Linda
    Cuaron, John
    Khan, Atif
    Yamada, Yoshiya
    Shin, Jacob Y.
    Beal, Kathryn
    Moss, Nelson S.
    Carlo, Maria I.
    Motzer, Robert J.
    Imber, Brandon S.
    Kotecha, Ritesh R.
    Pike, Luke R. G.
    EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (02): : 338 - 346